Vyrsa V1
Payments companies reported to CMS as associated with Vyrsa V1. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vyrsa V1, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vyrsa V1
These are the largest totals companies reported as associated with Vyrsa V1. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Brett Himmelwright | Camp Hill, PA | Orthopaedic Surgery | $137,773.44 |
| Gregory Bailey | State College, PA | Orthopaedic Surgery of The Spine | $77,301.72 |
| Micah Smith | Fort Wayne, IN | Orthopaedic Surgery | $51,726.00 |
| Pierce Nunley | Shreveport, LA | Orthopaedic Surgery | $51,226.00 |
| Alexander Escobar | Toledo, OH | Pain Medicine | $36,123.56 |
| Michael Dorsi | Thousand Oaks, CA | Neurological Surgery | $35,359.51 |
| Derek Haight | Draper, UT | Pain Medicine (Anesthesiology) | $31,505.35 |
| Jad Khalil | Southfield, MI | Orthopaedic Surgery | $30,690.29 |
| Ezell Askew | Lodi, CA | Interventional Pain Medicine | $27,481.76 |
| Thomas White | Shenandoah, TX | Interventional Pain Medicine | $24,235.66 |
Prescribed Vyrsa V1?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.